Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.
Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia.
Int J Lab Hematol. 2020 Jun;42(3):322-330. doi: 10.1111/ijlh.13183. Epub 2020 Mar 19.
Haemostatic balance shifted towards hypercoagulability in normal pregnancy is even more pronounced in pre-eclampsia (P-EC). The aim of this study was to analyse haemostatic disturbances and fibrin clot properties in women with pre-eclampsia and to investigate their association with maternal and foetal outcomes.
Forty-six pregnant women diagnosed with pre-eclampsia were included in the study, with blood sampling done on the morning following admission to hospital, as well as after delivery (mean duration 4.8 days). Two global haemostatic assays-endogenous thrombin potential (ETP) and assay of overall haemostatic potential (OHP)-were employed, including fibrin clot turbidity measurements and scanning electron microscopy (SEM) of representative samples.
Three thrombin generation parameters (ETP, t_lag and peak height) and OHP were significantly increased in pre-eclampsia compared with controls, whereas overall fibrinolytic potential (OFP-determined as a parameter of the OHP assay) had significantly lower values. Clot lysis time was significantly prolonged in patients with pre-eclampsia. In the pre-eclamptic group after delivery, we observed a significant elevation in the peak height and a reduction in the time to peak and OFP compared with values before delivery. Pre-eclamptic patients with renal complications had significantly higher values for ETP, peak height and D-dimer. Turbidity measurements and SEM revealed dense fibrin structure in patients with pre-eclampsia.
Patients with pre-eclampsia have enhanced coagulation and impaired fibrinolysis before, and even after, delivery. In particular, the presence of multi-organ dysfunction, such as renal dysfunction, may be associated with increased thrombin generation in pre-eclampsia.
正常妊娠时止血平衡向高凝状态的转变在子痫前期(PE)中更为明显。本研究旨在分析子痫前期患者的止血紊乱和纤维蛋白凝块特性,并探讨其与母婴结局的关系。
研究纳入了 46 例诊断为子痫前期的孕妇,在入院后次日清晨以及分娩后(平均持续 4.8 天)进行采血。采用两种全血凝血检测法——内源性凝血酶潜能(ETP)和整体凝血潜能检测(OHP),包括纤维蛋白凝块浊度测量和代表性样本的扫描电子显微镜(SEM)检查。
与对照组相比,子痫前期患者的三个凝血酶生成参数(ETP、t_lag 和峰高)和 OHP 显著升高,而整体纤维蛋白溶解潜能(OFP-作为 OHP 检测的一个参数来确定)显著降低。与对照组相比,子痫前期患者的凝块溶解时间显著延长。在分娩后的子痫前期组中,我们观察到与分娩前相比,峰高显著升高,达峰时间和 OFP 降低。伴有肾功能并发症的子痫前期患者的 ETP、峰高和 D-二聚体值显著升高。浊度测量和 SEM 显示子痫前期患者的纤维蛋白结构致密。
子痫前期患者在分娩前甚至分娩后都存在增强的凝血和受损的纤维蛋白溶解。特别是多器官功能障碍的存在,如肾功能障碍,可能与子痫前期时凝血酶生成增加有关。